[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Fabrice Andre<\/i><\/u><\/presenter>. Institute Gustave Roussy, Villejuif, France","CSlideId":"","ControlKey":"4b1485a3-42b7-44b5-99a8-d4f0138a23a7","ControlNumber":"570","DisclosureBlock":"&nbsp;<b>&nbsp;F. Andre:<\/b>  ; AstraZeneca. ; Eli Lilly and Company. ; Gilead Sciences Inc. ; Hoffmann-La Roche Limited. ; N-Power medicine. ; Novartis. ; Owkin. ; Pfizer Foundation. ; Servier Pharmaceuticals LLC. ; guardant health.","End":"4\/9\/2024 5:01:00 PM","HasWebcast":null,"Highlights":[],"Id":"149","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Fabrice Andre, MD, PhD","PresenterKey":"6353d4e4-035d-419a-80f6-2c431107220f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  5:00PM","SessionId":"72","SessionOnDemand":"False","SessionTitle":"Opportunities and Challenges in Leveraging Real-World Data to Accelerate Evidence Generation","ShowChatLink":"false","Start":"4\/9\/2024 5:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Fabrice Andre<\/i><\/u><\/presenter>. Institute Gustave Roussy, Villejuif, France","CSlideId":"","ControlKey":"600b2dbb-2b33-4199-be0b-b4de02a1669b","ControlNumber":"2457","DisclosureBlock":"<b>&nbsp;F. Andre, <\/b> <br><b>AstraZeneca<\/b> G. <br><b>Eli Lilly and Company<\/b> I, G. <br><b>Gilead Sciences Inc<\/b> I. <br><b>Hoffmann-La Roche Limited<\/b> G. <br><b>N-Power medicine<\/b> I. <br><b>Novartis<\/b> G. <br><b>Owkin<\/b> I. <br><b>Pfizer Foundation<\/b> G. <br><b>Servier Pharmaceuticals LLC<\/b> I. <br><b>guardant health<\/b> I.","End":"4\/9\/2024 5:05:00 PM","HasWebcast":null,"Highlights":[],"Id":"314","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Fabrice Andre, MD, PhD","PresenterKey":"6353d4e4-035d-419a-80f6-2c431107220f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chair Introduction","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  5:00PM","SessionId":"72","SessionOnDemand":"False","SessionTitle":"Opportunities and Challenges in Leveraging Real-World Data to Accelerate Evidence Generation","ShowChatLink":"false","Start":"4\/9\/2024 5:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chair Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Fabrice Andre<\/i><\/u><\/presenter>. Institute Gustave Roussy, Villejuif, France","CSlideId":"","ControlKey":"492b5533-7219-4503-915d-8d156fddc363","ControlNumber":"10980","DisclosureBlock":"<b>&nbsp;F. Andre, <\/b> <br><b>AstraZeneca<\/b> G. <br><b>Eli Lilly and Company<\/b> I, G. <br><b>Gilead Sciences Inc<\/b> I. <br><b>Hoffmann-La Roche Limited<\/b> G. <br><b>N-Power medicine<\/b> I. <br><b>Novartis<\/b> G. <br><b>Owkin<\/b> I. <br><b>Pfizer Foundation<\/b> G. <br><b>Servier Pharmaceuticals LLC<\/b> I. <br><b>guardant health<\/b> I.","End":"4\/9\/2024 5:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"8936","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Fabrice Andre, MD, PhD","PresenterKey":"6353d4e4-035d-419a-80f6-2c431107220f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Building and exploiting academic molecular databases (including AACR Project GENIE)","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  5:00PM","SessionId":"72","SessionOnDemand":"False","SessionTitle":"Opportunities and Challenges in Leveraging Real-World Data to Accelerate Evidence Generation","ShowChatLink":"false","Start":"4\/9\/2024 5:05:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Building and exploiting academic molecular databases (including AACR Project GENIE)","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Marc Hafner<\/i><\/u><\/presenter>. Genentech, South San Francisco, CA","CSlideId":"","ControlKey":"cf309e1e-6bc9-4c9f-a59e-06f1152f0795","ControlNumber":"11015","DisclosureBlock":"","End":"4\/9\/2024 5:35:00 PM","HasWebcast":null,"Highlights":[],"Id":"9565","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Marc Hafner, PhD","PresenterKey":"7f0e41e5-cd8f-411e-8095-2e892f0ce74b","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Leveraging clinico-genomics databases for R&#38;D","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  5:00PM","SessionId":"72","SessionOnDemand":"False","SessionTitle":"Opportunities and Challenges in Leveraging Real-World Data to Accelerate Evidence Generation","ShowChatLink":"false","Start":"4\/9\/2024 5:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Leveraging clinico-genomics databases for R&#38;D","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Paul G. Kluetz<\/i><\/u><\/presenter>. U.S. Food and Drug Administration, Silver Spring, MD","CSlideId":"","ControlKey":"7fb80652-42e8-4cc3-b25a-30a050872b96","ControlNumber":"11181","DisclosureBlock":"&nbsp;<b>P. G. Kluetz, <\/b> None.","End":"4\/9\/2024 5:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"9753","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Paul Kluetz, MD","PresenterKey":"4ac24004-87ac-4ca7-8651-bd0efe630dcd","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"What is the guidance of the FDA on the use of molecular data to generate RWE","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  5:00PM","SessionId":"72","SessionOnDemand":"False","SessionTitle":"Opportunities and Challenges in Leveraging Real-World Data to Accelerate Evidence Generation","ShowChatLink":"false","Start":"4\/9\/2024 5:35:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"What is the guidance of the FDA on the use of molecular data to generate RWE","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Garry P. Nolan<\/i><\/u><\/presenter>. Stanford University School of Medicine, Stanford, CA","CSlideId":"","ControlKey":"07482859-6376-4465-ae11-e5e513c941f6","ControlNumber":"12521","DisclosureBlock":"","End":"4\/9\/2024 6:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"12265","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Garry Nolan, PhD","PresenterKey":"1e6a4173-1456-4b80-8869-bb64ba036091","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Large language models for whole of PubMed dependent cancer data contextualization and hypothesis\/experiment formulations","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  5:00PM","SessionId":"72","SessionOnDemand":"False","SessionTitle":"Opportunities and Challenges in Leveraging Real-World Data to Accelerate Evidence Generation","ShowChatLink":"false","Start":"4\/9\/2024 5:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Large language models for whole of PubMed dependent cancer data contextualization and hypothesis\/experiment formulations","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":". ","CSlideId":"","ControlKey":"439be210-e44c-40aa-84d0-9e8a0dedc87a","ControlNumber":"2455","DisclosureBlock":"","End":"4\/9\/2024 6:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"313","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panel Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  5:00PM","SessionId":"72","SessionOnDemand":"False","SessionTitle":"Opportunities and Challenges in Leveraging Real-World Data to Accelerate Evidence Generation","ShowChatLink":"false","Start":"4\/9\/2024 6:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panel Discussion","Topics":null,"cSlideId":""}]